Homepage
Author:
Equillium, Inc.
Posted Date:
April 8, 2026
Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists
Equillium, Inc.
April 8, 2026
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Equillium, Inc.
April 2, 2026
Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights
Equillium, Inc.
March 25, 2026
Equillium to Participate in the 38th Annual Roth Conference
Equillium, Inc.
March 18, 2026
Equillium Announces $35 Million Financing with RA Capital Management
Equillium, Inc.
March 13, 2026
Equillium to Participate in the Leerink Partners 2026 Global Healthcare Conference
Equillium, Inc.
February 25, 2026
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Equillium, Inc.
February 2, 2026
